These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23644971)

  • 1. Fosfomycin-containing second-line treatment for Helicobacter pylori infection.
    Barahona-Garrido J; Quiñonez NF; Cerda-Contreras E; Maria Sarti H; Téllez-Ávila FI
    Am J Gastroenterol; 2013 May; 108(5):858-9. PubMed ID: 23644971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Helicobacter pylori resistance].
    Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2010 Jun; 172(26):2001; author reply 2001. PubMed ID: 20677399
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of helicobacter pylori infection].
    Kubisch CH; Gross MM
    MMW Fortschr Med; 2015 Jul; 157(13):43-5. PubMed ID: 26206036
    [No Abstract]   [Full Text] [Related]  

  • 4. [Helicobacter pylori: what schemes of eradication are essential today?].
    Maev IV; Samsonov AA; Golubev NN
    Ter Arkh; 2011; 83(8):41-4. PubMed ID: 21961331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori resistance].
    Alimoradi J; Rasmussen L; Andersen LP
    Ugeskr Laeger; 2010 May; 172(20):1516-21. PubMed ID: 20483098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin in first-line treatment of Helicobacter pylori infection.
    Rispo A; Di Girolamo E; Cozzolino A; Bozzi R; Morante A; Pasquale L
    Helicobacter; 2007 Aug; 12(4):364-5. PubMed ID: 17669111
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and eradication of a clinical isolate of Helicobacter pylori resistant to five antimicrobials in Germany.
    Wüppenhorst N; Lenze F; Ross M; Kist M
    J Antimicrob Chemother; 2011 Jan; 66(1):222-3. PubMed ID: 21051371
    [No Abstract]   [Full Text] [Related]  

  • 8. Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea.
    Lee BH; Kim N; Hwang TJ; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Helicobacter; 2010 Feb; 15(1):38-45. PubMed ID: 20302588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection.
    Carothers JJ; Bruce MG; Hennessy TW; Bensler M; Morris JM; Reasonover AL; Hurlburt DA; Parkinson AJ; Coleman JM; McMahon BJ
    Clin Infect Dis; 2007 Jan; 44(2):e5-8. PubMed ID: 17173210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Fischbach L; Evans EL
    Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
    Nagahara A; Sato N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
    [No Abstract]   [Full Text] [Related]  

  • 13. [Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance].
    Lengyel G; Zsolt T
    Orv Hetil; 2005 May; 146(18):839-42. PubMed ID: 15926629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Helicobacter pylori infection. Eradication treatment can be tailored in patients undergoing endoscopy.
    Parsons HK; Sanders DS; Carter MJ; Lobo AJ
    BMJ; 2002 Mar; 324(7337):614. PubMed ID: 11887888
    [No Abstract]   [Full Text] [Related]  

  • 15. Eradication therapy for Helicobacter pylori.
    Vakil N; Megraud F
    Gastroenterology; 2007 Sep; 133(3):985-1001. PubMed ID: 17854602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of Helicobacter pylori.
    McLoughlin R; Racz I; Buckley M; O'Connor HJ; O'Morain C
    Helicobacter; 2004; 9 Suppl 1():42-8. PubMed ID: 15347305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance in Helicobacter pylori isolates in Germany.
    Glocker E; Stueger HP; Kist M
    Antimicrob Agents Chemother; 2007 Jan; 51(1):346-9. PubMed ID: 17043117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate.
    Manfredi M; Bizzarri B; de'Angelis GL
    Helicobacter; 2012 Aug; 17(4):246-53. PubMed ID: 22759323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Helicobacter pylori infection 2010.
    O'Connor A; Gisbert JP; McNamara D; O'Morain C
    Helicobacter; 2010 Sep; 15 Suppl 1():46-52. PubMed ID: 21054653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of Helicobacter pylori to antibiotics and its impact on treatment options.
    Mégraud F
    Drug Resist Updat; 2001 Jun; 4(3):178-86. PubMed ID: 11768331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.